Cardiovascular Systems Inc. (CSII)

49.85
1.55 3.21
NASDAQ : Health Technology
Prev Close 48.30
Open 48.75
Day Low/High 48.65 / 50.50
52 Wk Low/High 24.84 / 50.50
Volume 471.06K
Avg Volume 271.50K
Exchange NASDAQ
Shares Outstanding 34.83M
Market Cap 1.68B
P/E Ratio 805.00
Div & Yield N.A. (N.A)
Cardiovascular Systems Completes Coast Study Enrollment In Japan

Cardiovascular Systems Completes Coast Study Enrollment In Japan

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced that it has completed enrollment in Japan for its Coronary Orbital Atherectomy System Trial (COAST) study.

Cardiovascular Systems Receives CE Mark For Stealth 360® Peripheral Orbital Atherectomy System

Cardiovascular Systems Receives CE Mark For Stealth 360® Peripheral Orbital Atherectomy System

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that it has received CE (Conformité Européenne) Mark for its Stealth 360º Orbital Atherectomy System (OAS).

Cardiovascular Systems Reports Fiscal 2015 First-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2015 First-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported...

Cardiovascular Systems Enrolls First Seven Patients In Japan For Coast Study

Cardiovascular Systems Enrolls First Seven Patients In Japan For Coast Study

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced that the first seven patients in Japan have been enrolled in its Coronary Orbital Atherectomy System Trial (COAST) study.

Cardiovascular Systems To Webcast Fiscal 2015 First-Quarter Earnings Conference Call Wednesday, October 29

Cardiovascular Systems To Webcast Fiscal 2015 First-Quarter Earnings Conference Call Wednesday, October 29

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2015 first-quarter conference call on Wednesday, October 29, 2014, at 3:45 p.

Cardiovascular Systems Becomes Oversold (CSII)

Cardiovascular Systems Becomes Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cardiovascular Systems, Inc.’s Board Chair To Retire

Cardiovascular Systems, Inc.’s Board Chair To Retire

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) today announced that its chairman of the board, Glen D.

Cardiovascular Systems Releases New Peripheral Data At 2014 TCT Conference

Cardiovascular Systems Releases New Peripheral Data At 2014 TCT Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), unveiled new data about the treatment of arterial calcification at the 2014 Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington D.

Cardiovascular Systems (CSII) Shares Cross Above 200 DMA

Cardiovascular Systems (CSII) Shares Cross Above 200 DMA

In trading on Thursday, shares of Cardiovascular Systems, Inc crossed above their 200 day moving average of $30.76, changing hands as high as $31.24 per share. Cardiovascular Systems, Inc shares are currently trading up about 9% on the day.

Cardiovascular Systems Reports Fiscal 2014 Fourth-Quarter And Full-Year Financial Results

Cardiovascular Systems Reports Fiscal 2014 Fourth-Quarter And Full-Year Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported...

Commit To Purchase Cardiovascular Systems At $22.50, Earn 12.8% Annualized Using Options

Commit To Purchase Cardiovascular Systems At $22.50, Earn 12.8% Annualized Using Options

Investors considering a purchase of Cardiovascular Systems, Inc stock, but cautious about paying the going market price of $27.15/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2015 put at the $22.50 strike, which has a bid at the time of this writing of $1.80.

Cardiovascular Systems To Webcast Fiscal 2014 Fourth-Quarter Earnings Conference Call Wednesday, August 6

Cardiovascular Systems To Webcast Fiscal 2014 Fourth-Quarter Earnings Conference Call Wednesday, August 6

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2014 fourth-quarter conference call on Wednesday, August 6, 2014, at 3:45 p.

Cardiovascular Systems Announces Plans For New Corporate Headquarters

Cardiovascular Systems Announces Plans For New Corporate Headquarters

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced plans to build a new corporate headquarters in New Brighton, Minn.

Cardiovascular Systems Enrolls First Patient In Coast Study

Cardiovascular Systems Enrolls First Patient In Coast Study

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), announced that the first patient has been enrolled in its Coronary Orbital Atherectomy System Trial (COAST) trial.

CSII Makes Bullish Cross Above Critical Moving Average

CSII Makes Bullish Cross Above Critical Moving Average

In trading on Wednesday, shares of Cardiovascular Systems, Inc crossed above their 200 day moving average of $28.71, changing hands as high as $28.94 per share. Cardiovascular Systems, Inc shares are currently trading up about 2.2% on the day.

Cardiovascular Systems Announces Coronary Data At Late-Breaker SCAI 2014 Scientific Sessions

Cardiovascular Systems Announces Coronary Data At Late-Breaker SCAI 2014 Scientific Sessions

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), presented one-year data and a new economic analysis from its ORBIT II coronary study in a late-breaker session at the Society for Cardiovascular Angiography and ...

Cardiovascular Systems Coronary Data Highlighted In Late-Breaking Presentation At EuroPCR Conference

Cardiovascular Systems Coronary Data Highlighted In Late-Breaking Presentation At EuroPCR Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced new one-year data and an economic analysis from its ORBIT II coronary study in a late-breaking presentation at the 2014 European Association of Percutaneous...

Cardiovascular Systems To Feature Late-Breaking Coronary Data At SCAI 2014 Scientific Sessions

Cardiovascular Systems To Feature Late-Breaking Coronary Data At SCAI 2014 Scientific Sessions

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will feature one-year data and an economic analysis from its ORBIT II coronary study in a late-breaking presentation at the Society for Cardiovascular Angiography and...

Cardiovascular Systems is Now Oversold (CSII)

Cardiovascular Systems is Now Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cardiovascular Systems (CSII) Marked As A Dead Cat Bounce Stock

Cardiovascular Systems (CSII) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Cardiovascular Systems (CSII) as a "dead cat bounce" (down big yesterday but up big today) candidate

Notable Two Hundred Day Moving Average Cross - CSII

Notable Two Hundred Day Moving Average Cross - CSII

In trading on Friday, shares of Cardiovascular Systems, Inc crossed below their 200 day moving average of $28.18, changing hands as low as $28.11 per share. Cardiovascular Systems, Inc shares are currently trading off about 2.5% on the day.

Insider Trading Alert - SM, KEX And CSII Traded By Insiders

Insider Trading Alert - SM, KEX And CSII Traded By Insiders

Stocks with insider trader activity include SM, KEX and CSII

Cardiovascular Systems Reports Fiscal 2014 Third-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2014 Third-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported...

Insider Trading Alert - CSII, PAG And CCE Traded By Insiders

Insider Trading Alert - CSII, PAG And CCE Traded By Insiders

Stocks with insider trader activity include CSII, PAG and CCE

Cardiovascular Systems To Webcast Fiscal 2014 Third-Quarter Earnings Conference Call Wednesday, April 30

Cardiovascular Systems To Webcast Fiscal 2014 Third-Quarter Earnings Conference Call Wednesday, April 30

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2014 third-quarter conference call on Wednesday, April 30, 2014, at 3:45 p.

Notable Two Hundred Day Moving Average Cross - CSII

Notable Two Hundred Day Moving Average Cross - CSII

In trading on Thursday, shares of Cardiovascular Systems, Inc crossed below their 200 day moving average of $27.54, changing hands as low as $27.12 per share. Cardiovascular Systems, Inc shares are currently trading down about 4.9% on the day.

Cardiovascular Systems Becomes Oversold (CSII)

Cardiovascular Systems Becomes Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Use Options For a Chance To Buy CSII at a 28% Discount

Use Options For a Chance To Buy CSII at a 28% Discount

Looking back to 133 days ago, Cardiovascular Systems, Inc priced a 2,608,696 share secondary stock offering at $30 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Wednesday, the stock is now 7.8% higher than the offering price.

Cardiovascular Systems Presenting ORBIT II Study One-Year Coronary Data During 2014 American College Of Cardiology Conference

Cardiovascular Systems Presenting ORBIT II Study One-Year Coronary Data During 2014 American College Of Cardiology Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will feature one-year data from the ORBIT II study of the company’s Diamondback 360 ® Coronary Orbital Atherectomy System.

Cardiovascular Systems' New 60cm Diamondback 360(R) Peripheral Orbital Atherectomy System Was Recently Cleared By The U.S. Food And Drug Administration To Treat Peripheral Arterial Disease (PAD). (Photo: Business Wire)

Cardiovascular Systems' New 60cm Diamondback 360(R) Peripheral Orbital Atherectomy System Was Recently Cleared By The U.S. Food And Drug Administration To Treat Peripheral Arterial Disease (PAD). (Photo: Business Wire)

Cardiovascular Systems, Inc. (NASDAQ: CSII) (CSI), today announced the first use of its Diamondback 360 ® 60cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).

TheStreet Quant Rating: C (Hold)